nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—Isoxsuprine—Propranolol—migraine	0.298	1	CrCrCtD
Phenylpropanolamine—ADRB2—Timolol—migraine	0.0768	0.155	CbGbCtD
Phenylpropanolamine—ADRB1—Timolol—migraine	0.0756	0.153	CbGbCtD
Phenylpropanolamine—ADRB2—Propranolol—migraine	0.0684	0.138	CbGbCtD
Phenylpropanolamine—ADRB1—Propranolol—migraine	0.0674	0.136	CbGbCtD
Phenylpropanolamine—SLC6A2—Amitriptyline—migraine	0.0495	0.1	CbGbCtD
Phenylpropanolamine—ADRA2A—Amitriptyline—migraine	0.0446	0.0902	CbGbCtD
Phenylpropanolamine—ADRA1A—Amitriptyline—migraine	0.0428	0.0865	CbGbCtD
Phenylpropanolamine—CYP1A2—Propranolol—migraine	0.0208	0.0421	CbGbCtD
Phenylpropanolamine—CYP1A2—Amitriptyline—migraine	0.018	0.0364	CbGbCtD
Phenylpropanolamine—CYP1A2—Valproic Acid—migraine	0.0164	0.0332	CbGbCtD
Phenylpropanolamine—CYP1A2—Verapamil—migraine	0.0143	0.0289	CbGbCtD
Phenylpropanolamine—Serotonin syndrome—Amitriptyline—migraine	0.00542	0.0663	CcSEcCtD
Phenylpropanolamine—SLC6A2—locus ceruleus—migraine	0.00465	0.118	CbGeAlD
Phenylpropanolamine—MAOA—locus ceruleus—migraine	0.00429	0.108	CbGeAlD
Phenylpropanolamine—SLC6A2—sympathetic nervous system—migraine	0.00368	0.093	CbGeAlD
Phenylpropanolamine—SLC6A2—autonomic nervous system—migraine	0.00247	0.0625	CbGeAlD
Phenylpropanolamine—DRD1—nerve—migraine	0.00214	0.0542	CbGeAlD
Phenylpropanolamine—Dyskinesia—Amitriptyline—migraine	0.00201	0.0247	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Amitriptyline—migraine	0.00193	0.0236	CcSEcCtD
Phenylpropanolamine—SLC6A3—nerve—migraine	0.00172	0.0436	CbGeAlD
Phenylpropanolamine—SLC6A2—nerve—migraine	0.00139	0.0352	CbGeAlD
Phenylpropanolamine—Irritability—Amitriptyline—migraine	0.00131	0.0161	CcSEcCtD
Phenylpropanolamine—Urinary retention—Amitriptyline—migraine	0.00131	0.016	CcSEcCtD
Phenylpropanolamine—Ataxia—Amitriptyline—migraine	0.00129	0.0158	CcSEcCtD
Phenylpropanolamine—MAOA—nerve—migraine	0.00128	0.0324	CbGeAlD
Phenylpropanolamine—ADRA2A—peripheral nervous system—migraine	0.00126	0.0319	CbGeAlD
Phenylpropanolamine—Liver injury—Valproic Acid—migraine	0.00119	0.0146	CcSEcCtD
Phenylpropanolamine—Irritability—Propranolol—migraine	0.00107	0.0131	CcSEcCtD
Phenylpropanolamine—Drowsiness—Amitriptyline—migraine	0.00106	0.013	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Valproic Acid—migraine	0.00102	0.0125	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Verapamil—migraine	0.001	0.0123	CcSEcCtD
Phenylpropanolamine—Hallucination—Amitriptyline—migraine	0.000946	0.0116	CcSEcCtD
Phenylpropanolamine—DRD1—brainstem—migraine	0.00092	0.0233	CbGeAlD
Phenylpropanolamine—Blood pressure increased—Timolol—migraine	0.000895	0.011	CcSEcCtD
Phenylpropanolamine—Dyskinesia—Gabapentin—migraine	0.000887	0.0109	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Valproic Acid—migraine	0.000863	0.0106	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Amitriptyline—migraine	0.000849	0.0104	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Gabapentin—migraine	0.000848	0.0104	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Gabapentin—migraine	0.000833	0.0102	CcSEcCtD
Phenylpropanolamine—Drowsiness—Verapamil—migraine	0.000793	0.00971	CcSEcCtD
Phenylpropanolamine—Vision blurred—Amitriptyline—migraine	0.00078	0.00955	CcSEcCtD
Phenylpropanolamine—Tremor—Amitriptyline—migraine	0.000775	0.00949	CcSEcCtD
Phenylpropanolamine—Hallucination—Propranolol—migraine	0.00077	0.00943	CcSEcCtD
Phenylpropanolamine—Agitation—Amitriptyline—migraine	0.00076	0.00931	CcSEcCtD
Phenylpropanolamine—Dyskinesia—Topiramate—migraine	0.000746	0.00913	CcSEcCtD
Phenylpropanolamine—SLC6A3—brainstem—migraine	0.00074	0.0187	CbGeAlD
Phenylpropanolamine—MAOA—neck—migraine	0.00072	0.0182	CbGeAlD
Phenylpropanolamine—Euphoric mood—Gabapentin—migraine	0.000716	0.00877	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Topiramate—migraine	0.000714	0.00874	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Valproic Acid—migraine	0.000712	0.00873	CcSEcCtD
Phenylpropanolamine—Anxiety—Amitriptyline—migraine	0.000702	0.0086	CcSEcCtD
Phenylpropanolamine—Ataxia—Valproic Acid—migraine	0.000686	0.0084	CcSEcCtD
Phenylpropanolamine—Confusional state—Amitriptyline—migraine	0.000681	0.00834	CcSEcCtD
Phenylpropanolamine—Flushing—Verapamil—migraine	0.000661	0.00809	CcSEcCtD
Phenylpropanolamine—Tachycardia—Amitriptyline—migraine	0.000659	0.00807	CcSEcCtD
Phenylpropanolamine—Hypotension—Amitriptyline—migraine	0.000631	0.00773	CcSEcCtD
Phenylpropanolamine—MAOA—trigeminal ganglion—migraine	0.000621	0.0157	CbGeAlD
Phenylpropanolamine—Agitation—Propranolol—migraine	0.000619	0.00758	CcSEcCtD
Phenylpropanolamine—Insomnia—Amitriptyline—migraine	0.000611	0.00748	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Topiramate—migraine	0.000602	0.00738	CcSEcCtD
Phenylpropanolamine—Somnolence—Amitriptyline—migraine	0.0006	0.00735	CcSEcCtD
Phenylpropanolamine—SLC6A2—brainstem—migraine	0.000597	0.0151	CbGeAlD
Phenylpropanolamine—Psychotic disorder—Gabapentin—migraine	0.000591	0.00723	CcSEcCtD
Phenylpropanolamine—Vision blurred—Verapamil—migraine	0.000584	0.00715	CcSEcCtD
Phenylpropanolamine—Tremor—Verapamil—migraine	0.000581	0.00711	CcSEcCtD
Phenylpropanolamine—Constipation—Amitriptyline—migraine	0.000577	0.00707	CcSEcCtD
Phenylpropanolamine—Irritability—Gabapentin—migraine	0.000577	0.00707	CcSEcCtD
Phenylpropanolamine—Urinary retention—Gabapentin—migraine	0.000575	0.00704	CcSEcCtD
Phenylpropanolamine—ADRB1—cardiovascular system—migraine	0.000573	0.0145	CbGeAlD
Phenylpropanolamine—Agitation—Verapamil—migraine	0.000569	0.00697	CcSEcCtD
Phenylpropanolamine—Ataxia—Gabapentin—migraine	0.000569	0.00696	CcSEcCtD
Phenylpropanolamine—Drowsiness—Valproic Acid—migraine	0.000562	0.00689	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Amitriptyline—migraine	0.000556	0.00681	CcSEcCtD
Phenylpropanolamine—ADRA1A—brainstem—migraine	0.000555	0.014	CbGeAlD
Phenylpropanolamine—MAOA—brainstem—migraine	0.00055	0.0139	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—TNF—migraine	0.000526	0.256	CrCbGaD
Phenylpropanolamine—Confusional state—Verapamil—migraine	0.00051	0.00624	CcSEcCtD
Phenylpropanolamine—DRD1—head—migraine	0.000509	0.0129	CbGeAlD
Phenylpropanolamine—Hallucination—Valproic Acid—migraine	0.000502	0.00615	CcSEcCtD
Phenylpropanolamine—Insomnia—Propranolol—migraine	0.000497	0.00609	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Topiramate—migraine	0.000497	0.00609	CcSEcCtD
Phenylpropanolamine—Tachycardia—Verapamil—migraine	0.000494	0.00604	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Propranolol—migraine	0.00049	0.006	CcSEcCtD
Phenylpropanolamine—Somnolence—Propranolol—migraine	0.000489	0.00599	CcSEcCtD
Phenylpropanolamine—Irritability—Topiramate—migraine	0.000486	0.00595	CcSEcCtD
Phenylpropanolamine—Urinary retention—Topiramate—migraine	0.000484	0.00593	CcSEcCtD
Phenylpropanolamine—DRD1—nervous system—migraine	0.000482	0.0122	CbGeAlD
Phenylpropanolamine—Ataxia—Topiramate—migraine	0.000478	0.00586	CcSEcCtD
Phenylpropanolamine—ADRA2A—trigeminal ganglion—migraine	0.000477	0.0121	CbGeAlD
Phenylpropanolamine—Hypotension—Verapamil—migraine	0.000473	0.00579	CcSEcCtD
Phenylpropanolamine—Constipation—Propranolol—migraine	0.00047	0.00576	CcSEcCtD
Phenylpropanolamine—Drowsiness—Gabapentin—migraine	0.000466	0.00571	CcSEcCtD
Phenylpropanolamine—DRD1—central nervous system—migraine	0.000464	0.0117	CbGeAlD
Phenylpropanolamine—Insomnia—Verapamil—migraine	0.000457	0.0056	CcSEcCtD
Phenylpropanolamine—ADRA1A—cardiovascular system—migraine	0.000453	0.0115	CbGeAlD
Phenylpropanolamine—Arrhythmia—Valproic Acid—migraine	0.000451	0.00552	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Verapamil—migraine	0.000451	0.00552	CcSEcCtD
Phenylpropanolamine—Somnolence—Verapamil—migraine	0.00045	0.00551	CcSEcCtD
Phenylpropanolamine—MAOA—cardiovascular system—migraine	0.000449	0.0113	CbGeAlD
Phenylpropanolamine—Hallucination—Timolol—migraine	0.000447	0.00547	CcSEcCtD
Phenylpropanolamine—Phentermine—SLC6A4—migraine	0.000447	0.217	CrCbGaD
Phenylpropanolamine—Dizziness—Amitriptyline—migraine	0.000446	0.00547	CcSEcCtD
Phenylpropanolamine—Constipation—Verapamil—migraine	0.000432	0.0053	CcSEcCtD
Phenylpropanolamine—Tension—Valproic Acid—migraine	0.000431	0.00528	CcSEcCtD
Phenylpropanolamine—Vomiting—Amitriptyline—migraine	0.000429	0.00526	CcSEcCtD
Phenylpropanolamine—Nervousness—Valproic Acid—migraine	0.000427	0.00523	CcSEcCtD
Phenylpropanolamine—Rash—Amitriptyline—migraine	0.000426	0.00521	CcSEcCtD
Phenylpropanolamine—Dermatitis—Amitriptyline—migraine	0.000425	0.00521	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—SLC6A4—migraine	0.000424	0.206	CrCbGaD
Phenylpropanolamine—Feeling abnormal—Verapamil—migraine	0.000417	0.0051	CcSEcCtD
Phenylpropanolamine—Hallucination—Gabapentin—migraine	0.000416	0.0051	CcSEcCtD
Phenylpropanolamine—Vision blurred—Valproic Acid—migraine	0.000414	0.00507	CcSEcCtD
Phenylpropanolamine—Tremor—Valproic Acid—migraine	0.000412	0.00504	CcSEcCtD
Phenylpropanolamine—SLC6A3—head—migraine	0.000409	0.0103	CbGeAlD
Phenylpropanolamine—Hypersensitivity—Propranolol—migraine	0.000405	0.00496	CcSEcCtD
Phenylpropanolamine—Agitation—Valproic Acid—migraine	0.000404	0.00494	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Timolol—migraine	0.000401	0.00492	CcSEcCtD
Phenylpropanolamine—Nausea—Amitriptyline—migraine	0.000401	0.00491	CcSEcCtD
Phenylpropanolamine—ADRB1—head—migraine	0.000388	0.00981	CbGeAlD
Phenylpropanolamine—SLC6A3—nervous system—migraine	0.000388	0.0098	CbGeAlD
Phenylpropanolamine—Tension—Timolol—migraine	0.000384	0.0047	CcSEcCtD
Phenylpropanolamine—Nervousness—Timolol—migraine	0.00038	0.00465	CcSEcCtD
Phenylpropanolamine—SLC6A3—central nervous system—migraine	0.000373	0.00944	CbGeAlD
Phenylpropanolamine—Anxiety—Valproic Acid—migraine	0.000373	0.00457	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Verapamil—migraine	0.000373	0.00456	CcSEcCtD
Phenylpropanolamine—DRD1—brain—migraine	0.000369	0.00932	CbGeAlD
Phenylpropanolamine—Vision blurred—Timolol—migraine	0.000369	0.00451	CcSEcCtD
Phenylpropanolamine—ADRB1—nervous system—migraine	0.000368	0.0093	CbGeAlD
Phenylpropanolamine—SLC6A3—cerebellum—migraine	0.000365	0.00922	CbGeAlD
Phenylpropanolamine—Dizziness—Propranolol—migraine	0.000364	0.00445	CcSEcCtD
Phenylpropanolamine—Confusional state—Valproic Acid—migraine	0.000362	0.00443	CcSEcCtD
Phenylpropanolamine—Tension—Gabapentin—migraine	0.000357	0.00438	CcSEcCtD
Phenylpropanolamine—ADRB1—central nervous system—migraine	0.000354	0.00895	CbGeAlD
Phenylpropanolamine—Nervousness—Gabapentin—migraine	0.000354	0.00433	CcSEcCtD
Phenylpropanolamine—Hallucination—Topiramate—migraine	0.00035	0.00429	CcSEcCtD
Phenylpropanolamine—Tachycardia—Valproic Acid—migraine	0.00035	0.00429	CcSEcCtD
Phenylpropanolamine—Vomiting—Propranolol—migraine	0.00035	0.00428	CcSEcCtD
Phenylpropanolamine—Rash—Propranolol—migraine	0.000347	0.00425	CcSEcCtD
Phenylpropanolamine—Dermatitis—Propranolol—migraine	0.000346	0.00424	CcSEcCtD
Phenylpropanolamine—Amphetamine—SLC6A4—migraine	0.000344	0.167	CrCbGaD
Phenylpropanolamine—Vision blurred—Gabapentin—migraine	0.000343	0.0042	CcSEcCtD
Phenylpropanolamine—Tremor—Gabapentin—migraine	0.000341	0.00418	CcSEcCtD
Phenylpropanolamine—Hypotension—Valproic Acid—migraine	0.000335	0.0041	CcSEcCtD
Phenylpropanolamine—Agitation—Gabapentin—migraine	0.000335	0.0041	CcSEcCtD
Phenylpropanolamine—Dizziness—Verapamil—migraine	0.000334	0.0041	CcSEcCtD
Phenylpropanolamine—Anxiety—Timolol—migraine	0.000332	0.00406	CcSEcCtD
Phenylpropanolamine—SLC6A2—head—migraine	0.00033	0.00834	CbGeAlD
Phenylpropanolamine—Flushing—Topiramate—migraine	0.000327	0.004	CcSEcCtD
Phenylpropanolamine—Nausea—Propranolol—migraine	0.000327	0.004	CcSEcCtD
Phenylpropanolamine—Insomnia—Valproic Acid—migraine	0.000324	0.00397	CcSEcCtD
Phenylpropanolamine—Confusional state—Timolol—migraine	0.000322	0.00394	CcSEcCtD
Phenylpropanolamine—Vomiting—Verapamil—migraine	0.000322	0.00394	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Valproic Acid—migraine	0.00032	0.00392	CcSEcCtD
Phenylpropanolamine—Rash—Verapamil—migraine	0.000319	0.00391	CcSEcCtD
Phenylpropanolamine—Somnolence—Valproic Acid—migraine	0.000319	0.0039	CcSEcCtD
Phenylpropanolamine—Dermatitis—Verapamil—migraine	0.000319	0.0039	CcSEcCtD
Phenylpropanolamine—Methamphetamine—SLC6A4—migraine	0.000318	0.155	CrCbGaD
Phenylpropanolamine—SLC6A2—nervous system—migraine	0.000313	0.00791	CbGeAlD
Phenylpropanolamine—Anxiety—Gabapentin—migraine	0.000309	0.00378	CcSEcCtD
Phenylpropanolamine—Constipation—Valproic Acid—migraine	0.000307	0.00376	CcSEcCtD
Phenylpropanolamine—ADRA1A—head—migraine	0.000307	0.00775	CbGeAlD
Phenylpropanolamine—MAOA—head—migraine	0.000304	0.00768	CbGeAlD
Phenylpropanolamine—SLC6A2—central nervous system—migraine	0.000301	0.00761	CbGeAlD
Phenylpropanolamine—Tension—Topiramate—migraine	0.000301	0.00368	CcSEcCtD
Phenylpropanolamine—Nausea—Verapamil—migraine	0.0003	0.00368	CcSEcCtD
Phenylpropanolamine—Confusional state—Gabapentin—migraine	0.0003	0.00367	CcSEcCtD
Phenylpropanolamine—Hypotension—Timolol—migraine	0.000298	0.00365	CcSEcCtD
Phenylpropanolamine—Nervousness—Topiramate—migraine	0.000298	0.00364	CcSEcCtD
Phenylpropanolamine—SLC6A3—brain—migraine	0.000296	0.00749	CbGeAlD
Phenylpropanolamine—Feeling abnormal—Valproic Acid—migraine	0.000295	0.00362	CcSEcCtD
Phenylpropanolamine—ADRA1A—nervous system—migraine	0.000291	0.00735	CbGeAlD
Phenylpropanolamine—Tachycardia—Gabapentin—migraine	0.00029	0.00355	CcSEcCtD
Phenylpropanolamine—Vision blurred—Topiramate—migraine	0.000289	0.00354	CcSEcCtD
Phenylpropanolamine—Insomnia—Timolol—migraine	0.000289	0.00354	CcSEcCtD
Phenylpropanolamine—MAOA—nervous system—migraine	0.000288	0.00729	CbGeAlD
Phenylpropanolamine—Tremor—Topiramate—migraine	0.000287	0.00352	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Timolol—migraine	0.000285	0.00349	CcSEcCtD
Phenylpropanolamine—Somnolence—Timolol—migraine	0.000284	0.00348	CcSEcCtD
Phenylpropanolamine—Agitation—Topiramate—migraine	0.000282	0.00345	CcSEcCtD
Phenylpropanolamine—ADRB1—brain—migraine	0.000281	0.00711	CbGeAlD
Phenylpropanolamine—ADRA1A—central nervous system—migraine	0.00028	0.00708	CbGeAlD
Phenylpropanolamine—Hypotension—Gabapentin—migraine	0.000278	0.0034	CcSEcCtD
Phenylpropanolamine—MAOA—central nervous system—migraine	0.000277	0.00701	CbGeAlD
Phenylpropanolamine—ADRA1A—cerebellum—migraine	0.000274	0.00692	CbGeAlD
Phenylpropanolamine—MAOA—cerebellum—migraine	0.000271	0.00686	CbGeAlD
Phenylpropanolamine—Insomnia—Gabapentin—migraine	0.000269	0.00329	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Gabapentin—migraine	0.000265	0.00325	CcSEcCtD
Phenylpropanolamine—Somnolence—Gabapentin—migraine	0.000264	0.00324	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Valproic Acid—migraine	0.000264	0.00324	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Timolol—migraine	0.000263	0.00322	CcSEcCtD
Phenylpropanolamine—Anxiety—Topiramate—migraine	0.00026	0.00318	CcSEcCtD
Phenylpropanolamine—Constipation—Gabapentin—migraine	0.000254	0.00311	CcSEcCtD
Phenylpropanolamine—Confusional state—Topiramate—migraine	0.000252	0.00309	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Gabapentin—migraine	0.000245	0.003	CcSEcCtD
Phenylpropanolamine—Tachycardia—Topiramate—migraine	0.000244	0.00299	CcSEcCtD
Phenylpropanolamine—SLC6A2—brain—migraine	0.000239	0.00604	CbGeAlD
Phenylpropanolamine—Dizziness—Valproic Acid—migraine	0.000237	0.0029	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Timolol—migraine	0.000235	0.00288	CcSEcCtD
Phenylpropanolamine—Hypotension—Topiramate—migraine	0.000234	0.00286	CcSEcCtD
Phenylpropanolamine—ADRA2A—head—migraine	0.000233	0.0059	CbGeAlD
Phenylpropanolamine—Vomiting—Valproic Acid—migraine	0.000228	0.00279	CcSEcCtD
Phenylpropanolamine—Insomnia—Topiramate—migraine	0.000226	0.00277	CcSEcCtD
Phenylpropanolamine—Rash—Valproic Acid—migraine	0.000226	0.00277	CcSEcCtD
Phenylpropanolamine—Dermatitis—Valproic Acid—migraine	0.000226	0.00277	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Topiramate—migraine	0.000223	0.00273	CcSEcCtD
Phenylpropanolamine—Somnolence—Topiramate—migraine	0.000222	0.00272	CcSEcCtD
Phenylpropanolamine—ADRA1A—brain—migraine	0.000222	0.00562	CbGeAlD
Phenylpropanolamine—ADRA2A—nervous system—migraine	0.000221	0.00559	CbGeAlD
Phenylpropanolamine—MAOA—brain—migraine	0.00022	0.00557	CbGeAlD
Phenylpropanolamine—Hypersensitivity—Gabapentin—migraine	0.000219	0.00268	CcSEcCtD
Phenylpropanolamine—Constipation—Topiramate—migraine	0.000214	0.00262	CcSEcCtD
Phenylpropanolamine—Nausea—Valproic Acid—migraine	0.000213	0.00261	CcSEcCtD
Phenylpropanolamine—ADRA2A—central nervous system—migraine	0.000213	0.00538	CbGeAlD
Phenylpropanolamine—Dizziness—Timolol—migraine	0.000211	0.00259	CcSEcCtD
Phenylpropanolamine—ADRA2A—cerebellum—migraine	0.000208	0.00526	CbGeAlD
Phenylpropanolamine—Feeling abnormal—Topiramate—migraine	0.000206	0.00252	CcSEcCtD
Phenylpropanolamine—Vomiting—Timolol—migraine	0.000203	0.00249	CcSEcCtD
Phenylpropanolamine—Rash—Timolol—migraine	0.000201	0.00246	CcSEcCtD
Phenylpropanolamine—Dermatitis—Timolol—migraine	0.000201	0.00246	CcSEcCtD
Phenylpropanolamine—Dizziness—Gabapentin—migraine	0.000197	0.00241	CcSEcCtD
Phenylpropanolamine—Nausea—Timolol—migraine	0.00019	0.00232	CcSEcCtD
Phenylpropanolamine—Vomiting—Gabapentin—migraine	0.000189	0.00231	CcSEcCtD
Phenylpropanolamine—Rash—Gabapentin—migraine	0.000187	0.0023	CcSEcCtD
Phenylpropanolamine—Dermatitis—Gabapentin—migraine	0.000187	0.00229	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Topiramate—migraine	0.000184	0.00226	CcSEcCtD
Phenylpropanolamine—Nausea—Gabapentin—migraine	0.000177	0.00216	CcSEcCtD
Phenylpropanolamine—ADRA2A—brain—migraine	0.000169	0.00427	CbGeAlD
Phenylpropanolamine—Dizziness—Topiramate—migraine	0.000165	0.00203	CcSEcCtD
Phenylpropanolamine—Vomiting—Topiramate—migraine	0.000159	0.00195	CcSEcCtD
Phenylpropanolamine—Rash—Topiramate—migraine	0.000158	0.00193	CcSEcCtD
Phenylpropanolamine—Dermatitis—Topiramate—migraine	0.000158	0.00193	CcSEcCtD
Phenylpropanolamine—Nausea—Topiramate—migraine	0.000149	0.00182	CcSEcCtD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.59e-05	0.00078	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—EDNRA—migraine	6.53e-05	0.000773	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CALCRL—migraine	6.47e-05	0.000766	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—RAMP1—migraine	6.47e-05	0.000766	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR2B—migraine	6.46e-05	0.000765	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.45e-05	0.000764	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CALCA—migraine	6.42e-05	0.000761	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR2B—migraine	6.4e-05	0.000758	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.38e-05	0.000756	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.31e-05	0.000747	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CALCA—migraine	6.28e-05	0.000744	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR2B—migraine	6.26e-05	0.000741	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR1D—migraine	6.25e-05	0.00074	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.15e-05	0.000728	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR1D—migraine	6.11e-05	0.000724	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	6.04e-05	0.000715	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—HTR7—migraine	6.01e-05	0.000712	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR1B—migraine	5.97e-05	0.000707	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.93e-05	0.000702	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—HTR7—migraine	5.88e-05	0.000696	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR2B—migraine	5.81e-05	0.000688	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR1A—migraine	5.75e-05	0.000681	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2B—migraine	5.68e-05	0.000673	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—NPS—migraine	5.66e-05	0.00067	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—TAC1—migraine	5.66e-05	0.00067	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RAMP1—migraine	5.65e-05	0.000669	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CALCRL—migraine	5.65e-05	0.000669	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR1D—migraine	5.57e-05	0.00066	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR2C—migraine	5.55e-05	0.000657	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR1B—migraine	5.55e-05	0.000657	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.53e-05	0.000654	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.41e-05	0.00064	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—EDNRA—migraine	5.4e-05	0.000639	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR1A—migraine	5.34e-05	0.000632	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—NPS—migraine	5.26e-05	0.000623	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—TAC1—migraine	5.26e-05	0.000623	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.22e-05	0.000618	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CALCA—migraine	5.2e-05	0.000616	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CACNA1A—migraine	5.18e-05	0.000614	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2B—migraine	5.18e-05	0.000613	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	5.17e-05	0.000613	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR2C—migraine	5.16e-05	0.000611	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RAMP1—migraine	5.08e-05	0.000602	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CALCRL—migraine	5.08e-05	0.000602	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR1D—migraine	5.06e-05	0.000599	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—EDNRA—migraine	5.02e-05	0.000594	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RAMP1—migraine	4.97e-05	0.000589	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CALCRL—migraine	4.97e-05	0.000589	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR7—migraine	4.86e-05	0.000576	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.85e-05	0.000574	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CALCA—migraine	4.83e-05	0.000572	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	4.81e-05	0.00057	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2B—migraine	4.7e-05	0.000557	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR1D—migraine	4.7e-05	0.000556	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—HTR2A—migraine	4.68e-05	0.000554	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—TNF—migraine	4.67e-05	0.000553	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR1B—migraine	4.64e-05	0.000549	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	4.57e-05	0.000542	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	4.57e-05	0.000542	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR7—migraine	4.52e-05	0.000535	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.47e-05	0.00053	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR1A—migraine	4.47e-05	0.000529	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—NPS—migraine	4.4e-05	0.000521	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—TAC1—migraine	4.4e-05	0.000521	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2B—migraine	4.37e-05	0.000517	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR2C—migraine	4.31e-05	0.000511	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR1B—migraine	4.21e-05	0.000499	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—HTR2A—migraine	4.21e-05	0.000498	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—EDNRA—migraine	4.19e-05	0.000497	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR1B—migraine	4.17e-05	0.000494	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.15e-05	0.000492	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—HTR2A—migraine	4.12e-05	0.000488	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RAMP1—migraine	4.11e-05	0.000487	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CALCRL—migraine	4.11e-05	0.000487	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR1D—migraine	4.11e-05	0.000486	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR1B—migraine	4.08e-05	0.000483	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR1A—migraine	4.05e-05	0.00048	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CALCA—migraine	4.04e-05	0.000478	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR1A—migraine	4.01e-05	0.000475	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—NPS—migraine	3.99e-05	0.000473	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—TAC1—migraine	3.99e-05	0.000473	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—TAC1—migraine	3.95e-05	0.000468	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—NPS—migraine	3.95e-05	0.000468	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR1A—migraine	3.93e-05	0.000465	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR2C—migraine	3.92e-05	0.000464	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR2C—migraine	3.88e-05	0.000459	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—NPS—migraine	3.87e-05	0.000458	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—TAC1—migraine	3.87e-05	0.000458	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RAMP1—migraine	3.82e-05	0.000452	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CALCRL—migraine	3.82e-05	0.000452	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2B—migraine	3.82e-05	0.000452	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—EDNRA—migraine	3.81e-05	0.000451	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR2C—migraine	3.79e-05	0.000449	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR1B—migraine	3.79e-05	0.000448	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR7—migraine	3.78e-05	0.000447	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—EDNRA—migraine	3.77e-05	0.000447	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR1B—migraine	3.7e-05	0.000439	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR1D—migraine	3.69e-05	0.000437	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—EDNRA—migraine	3.69e-05	0.000437	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CALCA—migraine	3.67e-05	0.000434	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR1A—migraine	3.65e-05	0.000432	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CALCA—migraine	3.63e-05	0.00043	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR1D—migraine	3.61e-05	0.000428	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—TAC1—migraine	3.59e-05	0.000425	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—NPS—migraine	3.59e-05	0.000425	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR1A—migraine	3.57e-05	0.000422	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CALCA—migraine	3.55e-05	0.000421	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR2C—migraine	3.52e-05	0.000417	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—NPS—migraine	3.51e-05	0.000416	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—TAC1—migraine	3.51e-05	0.000416	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CACNA1A—migraine	3.46e-05	0.00041	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2C—migraine	3.44e-05	0.000408	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2B—migraine	3.43e-05	0.000407	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR7—migraine	3.43e-05	0.000406	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—EDNRA—migraine	3.42e-05	0.000406	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR2A—migraine	3.41e-05	0.000403	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR7—migraine	3.4e-05	0.000402	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR1B—migraine	3.37e-05	0.0004	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—LRP1—migraine	3.36e-05	0.000398	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2B—migraine	3.36e-05	0.000398	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—EDNRA—migraine	3.35e-05	0.000397	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR7—migraine	3.32e-05	0.000393	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CALCA—migraine	3.3e-05	0.00039	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR1A—migraine	3.25e-05	0.000385	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CALCA—migraine	3.22e-05	0.000382	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—NPS—migraine	3.2e-05	0.000379	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—TAC1—migraine	3.2e-05	0.000379	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR2A—migraine	3.16e-05	0.000375	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2C—migraine	3.14e-05	0.000371	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	3.14e-05	0.000371	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR7—migraine	3.08e-05	0.000365	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR1B—migraine	3.06e-05	0.000363	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—EDNRA—migraine	3.05e-05	0.000361	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—LRP1—migraine	3.02e-05	0.000358	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	3.02e-05	0.000357	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR7—migraine	3.02e-05	0.000357	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR1D—migraine	2.99e-05	0.000354	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—TAC1—migraine	2.97e-05	0.000352	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—NPS—migraine	2.97e-05	0.000352	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—LRP1—migraine	2.96e-05	0.00035	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR1A—migraine	2.95e-05	0.000349	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CALCA—migraine	2.94e-05	0.000348	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	2.91e-05	0.000345	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TAC1—migraine	2.9e-05	0.000344	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—NPS—migraine	2.9e-05	0.000344	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2C—migraine	2.85e-05	0.000337	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR1B—migraine	2.85e-05	0.000337	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	2.84e-05	0.000336	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2B—migraine	2.78e-05	0.000329	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR1D—migraine	2.78e-05	0.000329	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—EDNRA—migraine	2.77e-05	0.000328	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR7—migraine	2.75e-05	0.000325	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR1A—migraine	2.74e-05	0.000325	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CALCA—migraine	2.73e-05	0.000323	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TAC1—migraine	2.7e-05	0.00032	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—NPS—migraine	2.7e-05	0.00032	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CALCA—migraine	2.67e-05	0.000316	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2C—migraine	2.65e-05	0.000313	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR2A—migraine	2.65e-05	0.000313	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2B—migraine	2.58e-05	0.000306	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOTCH4—migraine	2.58e-05	0.000305	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—EDNRA—migraine	2.57e-05	0.000305	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR7—migraine	2.55e-05	0.000302	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR7—migraine	2.49e-05	0.000295	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR1B—migraine	2.49e-05	0.000295	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CALCA—migraine	2.48e-05	0.000293	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LRP1—migraine	2.45e-05	0.00029	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR2A—migraine	2.4e-05	0.000284	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR1A—migraine	2.4e-05	0.000284	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR2A—migraine	2.38e-05	0.000282	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PGR—migraine	2.36e-05	0.000279	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TAC1—migraine	2.36e-05	0.000279	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NPS—migraine	2.36e-05	0.000279	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR2A—migraine	2.33e-05	0.000276	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOTCH4—migraine	2.32e-05	0.000275	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR7—migraine	2.32e-05	0.000275	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2C—migraine	2.31e-05	0.000274	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LRP1—migraine	2.27e-05	0.000269	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOTCH4—migraine	2.27e-05	0.000269	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—EDNRA—migraine	2.25e-05	0.000266	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR1B—migraine	2.24e-05	0.000265	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOTCH3—migraine	2.19e-05	0.00026	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR1B—migraine	2.19e-05	0.000259	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CALCA—migraine	2.17e-05	0.000257	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR2A—migraine	2.16e-05	0.000256	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR1A—migraine	2.15e-05	0.000255	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PGR—migraine	2.12e-05	0.000251	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NPS—migraine	2.12e-05	0.000251	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TAC1—migraine	2.12e-05	0.000251	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2A—migraine	2.11e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR1A—migraine	2.11e-05	0.000249	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2C—migraine	2.08e-05	0.000246	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PGR—migraine	2.07e-05	0.000246	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TAC1—migraine	2.07e-05	0.000246	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NPS—migraine	2.07e-05	0.000246	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2C—migraine	2.03e-05	0.000241	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR7—migraine	2.03e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EDNRA—migraine	2.02e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EDNRA—migraine	1.98e-05	0.000234	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOTCH3—migraine	1.97e-05	0.000233	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CALCA—migraine	1.95e-05	0.000231	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOTCH3—migraine	1.93e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2A—migraine	1.92e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CACNA1A—migraine	1.91e-05	0.000226	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CALCA—migraine	1.91e-05	0.000226	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOTCH4—migraine	1.88e-05	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR7—migraine	1.82e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR1B—migraine	1.81e-05	0.000214	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	1.79e-05	0.000212	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR7—migraine	1.78e-05	0.000211	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2A—migraine	1.75e-05	0.000207	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFBR2—migraine	1.74e-05	0.000207	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOTCH4—migraine	1.74e-05	0.000206	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR1A—migraine	1.74e-05	0.000206	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PGR—migraine	1.72e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NPS—migraine	1.72e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TAC1—migraine	1.72e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—MTHFR—migraine	1.71e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2C—migraine	1.68e-05	0.000199	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR1B—migraine	1.68e-05	0.000199	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EDNRA—migraine	1.64e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2A—migraine	1.62e-05	0.000192	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR1A—migraine	1.62e-05	0.000192	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOTCH3—migraine	1.6e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PGR—migraine	1.59e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TAC1—migraine	1.59e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NPS—migraine	1.59e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CALCA—migraine	1.58e-05	0.000187	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFBR2—migraine	1.57e-05	0.000186	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2C—migraine	1.56e-05	0.000185	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFBR2—migraine	1.53e-05	0.000182	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EDNRA—migraine	1.52e-05	0.00018	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOTCH3—migraine	1.48e-05	0.000176	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR7—migraine	1.47e-05	0.000175	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CALCA—migraine	1.46e-05	0.000173	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2A—migraine	1.42e-05	0.000168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR7—migraine	1.37e-05	0.000162	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2A—migraine	1.28e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFBR2—migraine	1.27e-05	0.00015	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ESR1—migraine	1.26e-05	0.000149	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2A—migraine	1.25e-05	0.000148	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFBR2—migraine	1.18e-05	0.00014	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—MTHFR—migraine	1.15e-05	0.000136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ESR1—migraine	1.13e-05	0.000134	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ESR1—migraine	1.11e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2A—migraine	1.03e-05	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2A—migraine	9.59e-06	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ESR1—migraine	9.16e-06	0.000109	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ESR1—migraine	8.51e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MTHFR—migraine	6.32e-06	7.49e-05	CbGpPWpGaD
